An Investigation of Pollen Extracts From Different Deciduous Trees in Patients With Springtime Allergy in Sweden

Zetterström, Olle; Fagerberg, E; Wide, Leif

doi:10.1111/j.1398-9995.1972.tb01638.x

Cited by 36 publications

(18 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The closely related birch family (Betulaceae; eg, birch, alder, hazel, hornbeam, and hop hornbeam) and oak (Fagaceae; eg, beech, oak, and chestnut) have strong cross-allergenicity. [83][84][85] Significant cross-reactivity between Betulaceae pollens and oak of the Fagaceae family has been demonstrated with percutaneous skin testing. 75 RAST inhibition studies have shown cross-inhibition between oaks and other Fagales species.…”

Section: Cross-reactivity Of Allergen Extractmentioning

confidence: 98%

Allergen immunotherapy: A practice parameter second update

Cox¹,

Li²,

Nelson³

et al. 2007

Journal of Allergy and Clinical Immunology

206

139

View full text Add to dashboard Cite

Section: Cross-reactivity Of Allergen Extractmentioning

confidence: 98%

Allergen immunotherapy: A practice parameter second update

Cox¹,

Li²,

Nelson³

et al. 2007

Journal of Allergy and Clinical Immunology

206

139

View full text Add to dashboard Cite

“…The closely related birch family (Betulaceae; eg, birch, alder, hazel, hornbeam, and hop hornbeam) and oak (Fagaceae; eg, beech, oak, and chestnut) have strong cross-allergenicity. 400,401 Significant cross-reactivity between Betulaceae pollens and oak of the Fagaceae family has been demonstrated with percutaneous skin testing. 386 RAST 378,379 Allergen extracts as compounding sterile preparations (CSPs) are single-and multiple-dose intradermal or subcutaneous injections that are prepared by specially trained physicians and personnel under their direct supervision.…”

Section: Cross-reactivity Of Allergen Extractmentioning

confidence: 98%

Allergen immunotherapy: A practice parameter third update

Cox

Nelson

Lockey

et al. 2011

Journal of Allergy and Clinical Immunology

1,026

1,054

View full text Add to dashboard Cite

“…Birch pollen allergens induce broad and complex patterns of IgE cross‐reactivity, although cross‐reactivity among allergens of birch pollen is predominantly observed in relation to the major allergen Bet v 1. Extracts of alder, hornbeam, hazel, oak, chestnut, and beech contain allergens that are homologs and cross‐reactive in vitro to Bet v 1 . Skin prick test (SPT) and radioallergosorbent test results support cross‐reactivity within the birch homologous group .…”

Section: Introductionmentioning

confidence: 94%

Birch pollen allergy in Europe

Biedermann

Winther

Till

et al. 2019

Allergy

246

186

View full text Add to dashboard Cite

Birch and other related trees of the families Betulaceae and Fagaceae (alder, hazel, oak, hornbeam, chestnut, and beech) constitute the birch homologous group. This grouping is primarily based on the extensive IgE cross-reactivity of allergen homologs to the major birch allergen Bet v 1. Birch pollen is the most dominant tree pollen in Northern and Central Europe and is a major cause of allergic rhinitis and, possibly, asthma symptoms. Over the last few decades, levels of birch pollen have risen and the period of exposure has increased due to climate changes. Subsequently, the prevalence of birch pollen sensitization has also increased. The cross-reactivity and sequential pollen seasons within the birch homologous group create a prolonged symptomatic allergy period beyond birch pollen alone. Furthermore, many plant food allergens contain homologs to Bet v 1, meaning that the majority of patients with birch pollen allergy suffer from secondary pollen food syndrome (PFS). As a result, the negative impact on health-related quality of life (HRQoL) in patients allergic to birch pollen is significant. The purpose of this manuscript was to narratively review topics of interest such as taxonomy, cross-reactivity, prevalence, clinical relevance, PFS, and HRQoL with regard to birch pollen allergy from a European perspective.

show abstract

An Investigation of Pollen Extracts From Different Deciduous Trees in Patients With Springtime Allergy in Sweden

Cited by 36 publications

References 2 publications

Allergen immunotherapy: A practice parameter second update

Allergen immunotherapy: A practice parameter second update

Allergen immunotherapy: A practice parameter third update

Birch pollen allergy in Europe

Contact Info

Product

Resources

About